D L Carlson Investment Group Inc. Sells 778 Shares of Coca-Cola European Partners PLC (NYSE:CCEP)

Share on StockTwits

D L Carlson Investment Group Inc. trimmed its position in Coca-Cola European Partners PLC (NYSE:CCEP) by 0.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 84,335 shares of the company’s stock after selling 778 shares during the quarter. Coca-Cola European Partners accounts for 1.5% of D L Carlson Investment Group Inc.’s holdings, making the stock its 21st largest holding. D L Carlson Investment Group Inc.’s holdings in Coca-Cola European Partners were worth $4,676,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in CCEP. BlackRock Inc. bought a new stake in shares of Coca-Cola European Partners during the second quarter worth $634,950,000. Boston Partners bought a new stake in shares of Coca-Cola European Partners during the second quarter worth $336,519,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in shares of Coca-Cola European Partners during the second quarter worth $240,454,000. Invesco Ltd. bought a new stake in shares of Coca-Cola European Partners during the second quarter worth $230,595,000. Finally, Wells Fargo & Company MN bought a new stake in shares of Coca-Cola European Partners during the second quarter worth $212,214,000. 29.14% of the stock is currently owned by institutional investors and hedge funds.

CCEP has been the topic of a number of research reports. Liberum Capital initiated coverage on shares of Coca-Cola European Partners in a research note on Thursday, September 19th. They set a “buy” rating on the stock. Deutsche Bank reaffirmed a “buy” rating and set a $65.00 target price (up previously from $62.00) on shares of Coca-Cola European Partners in a research note on Tuesday, October 15th. ValuEngine raised shares of Coca-Cola European Partners from a “strong sell” rating to a “sell” rating in a research note on Friday, November 1st. Evercore ISI reaffirmed a “buy” rating and set a $60.00 target price on shares of Coca-Cola European Partners in a research note on Thursday, August 8th. Finally, Zacks Investment Research cut shares of Coca-Cola European Partners from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $58.80.

NYSE CCEP opened at $51.29 on Friday. The stock has a market cap of $25.18 billion, a PE ratio of 18.86, a PEG ratio of 2.06 and a beta of 0.41. The firm’s fifty day moving average price is $55.44 and its two-hundred day moving average price is $55.74. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.62 and a current ratio of 0.84. Coca-Cola European Partners PLC has a fifty-two week low of $44.44 and a fifty-two week high of $58.94.

About Coca-Cola European Partners

Coca-Cola European Partners plc, together with its subsidiaries, produces, markets, distributes, and sells a range of nonalcoholic ready-to-drink beverages. The company offers sparkling flavors, energy drinks, juices, isotonics, and other drinks, as well as water. It provides its products primarily under the Coca-Cola, Fanta, and Sprite brands, as well as Coca-Cola Zero Sugar, Mezzo Mix, Schweppes, Royal Bliss, Fïnle, Monster, GLACÉAU Smartwater, Vio, Chaudfontaine, Fuze Tea, Honest Coffee, Oasis, Capri-Sun, Honest, and Tropico brands.

Featured Article: How to track put option volume

Institutional Ownership by Quarter for Coca-Cola European Partners (NYSE:CCEP)

Receive News & Ratings for Coca-Cola European Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coca-Cola European Partners and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.